Title : 90Y-ibritumomab therapy in refractory non-Hodgkin's lymphoma: observations from 111In-ibritumomab pretreatment imaging.

Pub. Date : 2008 Nov

PMID : 18927323






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 90Y-ibritumomab is an antibody targeting CD20 receptors on the surface of lymphocytes. ibritumomab tiuxetan keratin 20 Homo sapiens